Follow Us All RSS About Us

Message Boards

or

Twitter

or

Social Profile

Most popular: AAPL AMD BJCT BMSN CHK CPYE DIS F FMD FTWR GLD KERX
  • StockTalk Live
  • OTC Live
  • ETFs Live
  • Forex Live
  • Top Searches
  • Twitter BuZZ
  • Web BuZZ

ANPI (Angiotech Pharmaceuticals)

remove frame
Back to Search
« Prev Mesg
Next Mesg »
Tweet This

Yahoo! Finance

angioedupro
Viropharma Analyst comments from 7/29 "We are afraid the end is near" on Vancocin!
Triangle pullback DRAM SUF NLST
Re: If I could only get him to push the FDA
Re: If I could only get him to push the FDA
Re: FDA Vancocin decision updated - Delay
Re: FDA Vancocin decision updated - Delay

ADFN InvestorsHub

The new management is GREAT!!!! ....
I'm glad to be in and I'm ejoying
A strong, steady uptrend is underway... looks fantastic!
How nice it is!!!!!! $2.00 here we come!!!
This is crazy action AH....$1.29, $1.39, $1.49... WTF.

Google Finance

TURNED $1,000 INTO OVER $2 MILLION IN JUST A FEW MONTHS.. TRY IT
!EXCELLENT TRADING ALERTS - TURNED $1000 INTO 2 MILLION !!! HIGHLY RECOMMENDED #!!
EXCELLENT TRADING ALERTS - TURNED $1000 INTO 2 MILLION !!! HIGHLY RECOMMENDED !!
we just need some
America Under Siege - Check out HSCC

InvestorVillage

Ready to Breakout?
Ready to Breakout?

ClearStation

closing long (Closing Long Recommendation)...

TheLion

AKRX alerted yesterday eom
Re: alerted gone .... eom
alerted eom
akrx HOD eom
Re: Akorn also announces the launch of the generic version of Acular (Ketorol...
All RSS

About BoardCentral | Contact | Advertise

© 1999-2008 BoardCentralTM Inc. All Rights Reserved. Privacy statement and Disclaimer

Privacy statement and Terms of Use. Questions, comments, suggestions or disputes – please contact us. All copyrights, trademarks and other intellectual property rights referred to on these pages belong to their respective owners. By using this site you are agreeing to our terms of use, and agree not to redistribute the information found therein. All information provided on this site is "as is" and provided for informational and entertainment purposes only, not intended for trading purposes and should not be considered as investment advice.